Cargando…
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines...
Autores principales: | Eyal, Nir, Lipsitch, Marc, Smith, Peter G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184325/ https://www.ncbi.nlm.nih.gov/pubmed/32232474 http://dx.doi.org/10.1093/infdis/jiaa152 |
Ejemplares similares
-
Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine
Licensure Due to Ethical and Practical Issues
por: Spinola, Stanley M, et al.
Publicado: (2020) -
Corrigendum to: Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure due to Ethical and Practical Issues
por: Spinola, Stanley M, et al.
Publicado: (2021) -
Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012) -
How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available
por: Eyal, Nir, et al.
Publicado: (2021) -
Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
por: Steuwer, Bastian, et al.
Publicado: (2021)